AEON insider buying and SEC filings, explained
AEON Biopharma, Inc. · CIK 1837607
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Priveterra Acquisition Corp.
Insider activity in the last 12 months
Bought
$242K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 19, 2026 | Purchase (code P) | Timothy P. Lynch (10% owner) bought 1,150,000 shares at about $0.2100 ($242K), reported as a purchase (code P). Holdings up 21% to 6,500,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 21, 2026 |
10 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 8:42 AM ET 8-K | Material agreement (Item 1.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AEON in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.